Post-exam PHA491

Post-exam PHA491

University

5 Qs

quiz-placeholder

Similar activities

SR I- Quiz sur la terminologie gaz médicaux

SR I- Quiz sur la terminologie gaz médicaux

University

8 Qs

Homework Week 4

Homework Week 4

University

9 Qs

Fundamentals of Radiation Biology

Fundamentals of Radiation Biology

University

10 Qs

burn injury and the management

burn injury and the management

University

10 Qs

Metodologi Penelitian II

Metodologi Penelitian II

University

8 Qs

rancangan penelitian

rancangan penelitian

University

10 Qs

Quiz Epidemiologi dan Farmakovigilans

Quiz Epidemiologi dan Farmakovigilans

University

10 Qs

ODP Mouthrinse presentation

ODP Mouthrinse presentation

University

10 Qs

Post-exam PHA491

Post-exam PHA491

Assessment

Quiz

Health Sciences

University

Hard

Created by

Thaniya Wunnakup

FREE Resource

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

The optimum dose for the therapy is determined in which phase of the clinical trial?

Phase 3

Phase 2

Phase 1

Phase 4

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Cohort study is an observational study ?

True

False

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In case-control study, the cases are:

Individual with the exposure of interest

Individual without the disease

Individual with the disease

Individual from the general population

4.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

What is the main difference between a prospective cohort study and a case-control study?

A prospective cohort study is an observational study, while a case-control study is an experimental study.

A prospective cohort study measure outcome before exposure, while a case-control study measure exposure before outcome.

A prospective cohort study measure exposure before outcome , while a case-control study measure outcome before exposure.

A prospective cohort study is longitudinal study, while a case-control study is a cross-sectional study.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In a cross-over type of study design, participants:

Are divided into more than two groups

Stay in the same group throughout the study

Are never exposed to a placebo

Experience both active treatment and placebo at different times